Literature DB >> 15509643

Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.

Jian-Wen Chen1, Kurt Højlund, Henning Beck-Nielsen, Jens Sandahl Christiansen, Hans Orskov, Jan Frystyk.   

Abstract

Pituitary GH secretion is feedback regulated by circulating IGF-I. However, it remains to be determined whether the feedback control is mediated through circulating free or total IGF-I. To study this, we compared the temporal changes in circulating levels of GH vs. free and total IGF-I during fasting. Seventeen healthy normal-weight subjects (body mass index 23.4 +/- 0.6 kg/m(2)) were studied during 80 h of fasting. Serum was assayed for GH every 3 h; total, free, and bioactive IGF-I, IGF binding protein (IGFBP)-1, -2, and -3 as well as IGFBP-1 bound IGF-I were assayed every morning. During fasting, mean 24-h GH levels increased from 1.41 +/- 0.20 to 3.01 +/- 0.46 and 2.09 +/- 0.30 microg/liter (d 1 vs. d 2 and 3; P < 0.03). After 24 h of fasting, free and bioactive IGF-I had decreased by 40 +/- 5 and 17 +/- 5%, respectively (P < 0.02), and both concentrations remained suppressed for the rest of the study. In contrast, total IGF-I remained unchanged until the end of d 3, at which levels were slightly reduced (P < 0.007). IGFBP-1 increased from 38 +/- 2 to 137 +/- 24, 212 +/- 32, and 214 +/- 22 microg/liter (d 1 vs. d 2, d 3, and end of d 3; P < 0.0001), and these changes closely paralleled those of IGFBP-1-bound IGF-I (P < 0.0001). IGFBP-2 increased only transiently at d 2 (P < 0.05), and IGFBP-3 remained unchanged. The increase in mean 24-h GH levels from d 1 to d 2 correlated inversely with the relative reduction in free IGF-I from d 1 to d 2 (r = -0.51; P = 0.04), i.e. the larger the reduction in free IGF-I, the larger the increase in GH. None of the other IGF-related parameters correlated with GH. In conclusion, the temporal relationship between the increase in GH and the reduction in free IGF-I supports the hypothesis that circulating free IGF-I mediates the feedback regulation of GH secretion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509643     DOI: 10.1210/jc.2004-0039

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

2.  Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study.

Authors:  Graziano Onder; Rosa Liperoti; Andrea Russo; Ettore Capoluongo; Angelo Minucci; Paola Lulli; Matteo Cesari; Marcello Maggio; Roberto Bernabei; Francesco Landi
Journal:  Eur J Clin Pharmacol       Date:  2007-02-02       Impact factor: 2.953

3.  Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia.

Authors:  Andrea S Cornford; Ariel L Barkan; Jeffrey F Horowitz
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

4.  Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration.

Authors:  Chung-Jung Chiu; Yvette P Conley; Michael B Gorin; Gary Gensler; Chao-Qiang Lai; Fu Shang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

5.  Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.

Authors:  Johannes D Veldhuis; Dana Erickson; John M Miles; Cyril Y Bowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-05       Impact factor: 4.310

6.  Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.

Authors:  Shoshana Yakar; Clifford J Rosen; Mary L Bouxsein; Hui Sun; Wilson Mejia; Yuki Kawashima; Yingjie Wu; Kelly Emerton; Valerie Williams; Karl Jepsen; Mitchell B Schaffler; Robert J Majeska; Oksana Gavrilova; Mariana Gutierrez; David Hwang; Patricia Pennisi; Jan Frystyk; Yves Boisclair; John Pintar; Héctor Jasper; Horacio Domene; Pinchas Cohen; David Clemmons; Derek LeRoith
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

Review 7.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

8.  Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; John M Miles; Cyril Y Bowers
Journal:  Eur J Endocrinol       Date:  2009-05-20       Impact factor: 6.664

9.  Leptin does not mediate short-term fasting-induced changes in growth hormone pulsatility but increases IGF-I in leptin deficiency states.

Authors:  Jean L Chan; Catherine J Williams; Patricia Raciti; Jennifer Blakeman; Theodore Kelesidis; Iosif Kelesidis; Michael L Johnson; Michael O Thorner; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

10.  Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance.

Authors:  A Rickenlund; M Thorén; A Nybacka; J Frystyk; A Lindén Hirschberg
Journal:  Hum Reprod       Date:  2009-10-19       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.